The RTÉ favourite revealed that her daughter spent three days in Crumlin Children's Hospital after contracting RSV and she ...

Health officials are urging folks to get their flu and COVID vaccines as we head into the colder months because that’s when ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

Dr. Victoria Weston, emergency medicine physician, Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about the difference between and emergency department and an urgent care ...

Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...

GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...

Pfizer has terminated development of its RSV treatment candidate sisunatovir, a viral inhibitor picked up in its up to $525 ...

The Oklahoma State Department of Health is sharing highlights to be proactive during respiratory season as each year ...

Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and GSK said it expects revaccination will eventually be needed.

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

COVID-19 disrupted established patterns of seasonal transmission for several major respiratory Illnesses, with the exception of rhinovirus.